Antigenic and Biological Characteristics of Mutant Strains of Cryptococcus neoformans Lacking Capsular O Acetylation or Xylosyl Side Chains
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cryptococcus neoformans is surrounded by an antiphagocytic polysaccharide capsule whose primary constituent is glucuronoxylomannan (GXM). Three prominent structural features of GXM are single xylosyl and glucuronosyl side chains and O acetylation of the mannose backbone. Isogenic pairs of O-acetyl-positive and O-acetyl-negative strains (cas1Δ) as well as xylose-positive and xylose-negative strains (uxs1Δ) of serotype D have been reported. The cas1Δ strains were hypervirulent, and the uxs1Δ strains were avirulent. The goal of this study was to examine the effects of the cas1Δ and uxs1Δ mutations on the following: (i) binding of anti-GXM monoclonal antibodies (MAbs) in capsular quellung reactions, (ii) activation of the complement system and binding of C3, (iii) phagocytosis by neutrophils, and (iv) clearance of GXM in vivo. The results showed that loss of O acetylation produced dramatic changes in the reactivities of five of seven anti-GXM MAbs. In contrast, loss of xylosylation produced a substantive alteration in the binding behavior of only one MAb.O-acetyl-negative strains showed no alteration in activation and binding of C3 from normal serum. Xylose-negative strains exhibited accelerated kinetics for C3 deposition. Loss of O acetylation or xylosylation had no effect on phagocytosis of serum-opsonized yeast cells by human neutrophils. Finally, loss of O acetylation or xylosylation altered the kinetics for clearance of GXM from serum and accumulation of GXM in the liver and spleen. These results show that O acetylation and/or xylosylation are important for binding of anti-GXM MAbs, for complement activation, and for tissue accumulation of GXM but do not impact phagocytosis by neutrophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Neutrophil-Mediated Nonoxidative Antifungal Activity against Cryptococcus neoformans
Mambula, S. S., Simons, E. R., Hastey, R., Selsted, M. E., & Levitz, S. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6257-6264.2000 · Cited by 104 · cited 1×
“neutrophils (PMN) were grown as described previously (34).”
MethodSelf-citationActivation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
Kozel, T. R., & Pfrommer, G. S. (1986) · Infection and Immunity · doi:10.1128/iai.52.1.1-5.1986 · Cited by 102 · cited 1×
“This is an attractive hypothesis because previous studies have shown that C3b bound to the cryptococcal capsule is rapidly converted to iC3b (29, 40).”
ResultSelf-citationKozel, T. R., Wilson, M. A., & Murphy, J. W. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3101-3110.1991 · Cited by 86 · cited 2×
“Cryptococcal polysaccharide and the cryptococcal capsule have numerous biological activities that may contribute to the virulence of the yeast, such as inhibition of phagocytosis (5, 28), induction of immune unresponsiveness (26, 36), binding to phagocyte surface receptors, such as Toll 2, Toll 4, CD14, and CR3 (13, 4…”
BackgroundResultSelf-citation
Cited by
Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans
Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., & Casadevall, A. (2009) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(09)01204-0 · Cited by 457
The Cryptococcus neoformans Capsule: a Sword and a Shield
O'Meara, T. R., & Alspaugh, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-12 · Cited by 364
Doering, T. L. (2009) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162753 · Cited by 220
“neoformans, and several have been analyzed in detail (44, 86, 109, 159), but the specific epitopes they recognize are not known and may not be exclusive to capsule components.”
Virulence-Associated Enzymes of Cryptococcus neoformans
Almeida, F., Wolf, J. M., & Casadevall, A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00103-15 · Cited by 141
The capsular dynamics of Cryptococcus neoformans
McFadden, D., Zaragoza, O., & Casadevall, A. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.09.003 · Cited by 93
“Virulence studies with the Dcas1 strain suggest that the acetyl group on GXM reduces the virulence of the fungus [ 25 ].”
Background
Metadata
- Authors
- Kozel, T. R., Levitz, S. M., Dromer, F., Gates, M. A., Thorkildson, P., & Janbon, G.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2003-05
- Volume
- 71
- Issue
- 5
- Pages
- 2868-2875
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2103669668
- Cited by
- 78
- References
- 3
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antigenic and Biological Characteristics of Mutant Strains of Cryptococcus neoformans Lacking Capsular O Acetylation or Xylosyl Side Chains. https://app.cochat.ai/papers/10.1128/iai.71.5.2868-2875.2003
- The paper
- Kozel, T. R., Levitz, S. M., Dromer, F., Gates, M. A., Thorkildson, P., & Janbon, G. (2003). Antigenic and Biological Characteristics of Mutant Strains of Cryptococcus neoformans Lacking Capsular O Acetylation or Xylosyl Side Chains. Infection and Immunity. https://doi.org/10.1128/iai.71.5.2868-2875.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.